NTRA:NASDAQ
Natera Inc
$341.79
0.00%
(0.00) 1D
$342.99
arrow_upward
+0.35% (+1.20)bedtimeAfter hours
Closed: Sep 14, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Mkt. cap
49.27B
Avg. vol.
1.31M
Volume
452.00
52-wk high
$343.18
52-wk low
$157.42
EPS
-$1.37
Beta
1.54
Shares outstanding
144.14M
No. of employees
6K
Mkt. cap
49.27B
Avg. vol.
1.31M
Volume
452.00
52-wk high
$343.18
52-wk low
$157.42
EPS
-$1.37
Beta
1.54
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
Investing.com
·
23 hours ago
Natera at Morgan Stanley conference: mrD growth, new bets
Investing.com
·
3 days ago
Natera executive chairman Matthew Rabinowitz sells $16.4m in shares
Stock Titan
·
3 days ago
Executive chair of Natera (NTRA) sells 50,000 shares
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com